USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual ...

A recent research presented at the ENDO 2025 revealed that high blood sugar levels can impact men's sexual health. The ...

Over the course of two months and 12 treatments, 32 study participants ages 41 to 78 self-treated with the radio waves. Outcomes were evaluated using a questionnaire. One month after treatment, 28 ...

Researchers in the U.K. found that men prescribed erectile dysfunction drugs were 18% less likely to develop Alzheimer’s disease years later. Alzheimer’s Association Dr. Ozama Ismail weighed in.

The study followed over 269,000 participants for five years, and those who were prescribed erectile dysfunction drugs were 18% less likely to develop Alzheimer’s than those who weren’t.

UTMB Health study says erectile dysfunction meds associated with reductions — but not where you might think 😅 Ahmed Humble , Digital Content Producer Published: November 19, 2024 at 11:38 AM ...

Tirzepatide, the active ingredient in the diabetes drug Mounjaro, helped people lose more than 60 pounds (lb), or at least one-quarter of their body weight, when used along with intensive ...

Erectile dysfunction (ED) affects up to 66% of diabetic men globally, with risk factors like age, long-term diabetes, and obesity playing a significant role. The study emphasizes the urgent need ...

The study, which involved more than 1,000 prediabetic patients, found that those taking the highest dose of 15 mg lost 23% of their body weight, while those on a placebo lost just 2%. Tirzepatide is ...

Tirzepatide, a new injectable weight-loss drug with the trade name Zepbound, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period ...